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Abstract
An important challenge in biology has been to understand how cell-type-specific expression programs are
orchestrated through regulated access to chromatin. Knowledge of the interaction between noncoding RNAs
(ncRNAs) and chromatin regulators has the potential to help answer such questions, but how ncRNAs target
chromatin regulators to specific sites in the genome is not well understood. Recently, Jeon and Lee proposed that
DNA-binding proteins act as a bridge between ncRNAs and their target sites in chromatin. In this minireview, we
examine their findings and place them in the wider context of how chromatin regulator-RNA complexes are
targeted to specific sites in chromatin.
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Introduction
A number of noncoding RNAs (ncRNAs) have been
demonstrated to play a role in transcriptional or chro-
matin regulation through their interaction with chroma-
tin-modifying enzymes and transcription factors. Some
of these RNAs can be visualised to be associated with
specific loci, most strikingly the coating of the inactive
Xc h r o m o s o m e( X i )b yXi n a c t i v e - s p e c i f i ct r a n s c r i p t
(Xist) RNA. Modulation of a number of ncRNAs leads
to changes in the targeting of regulatory complexes to
specific genomic sites. Mechanisms must therefore be in
operation that direct ncRNA-protein complexes to spe-
cific sites in the genome.
Role of the DNA-binding protein YY1 in the localisation
of Xist RNA
Dosage compensation in female mammals is achieved by
silencing one copy of the two X chromosomes, termed
‘X-chromosome inactivation’ (XCI). The long ncRNA
Xist is the key factor in initiating this process [1]. Xist is
transcribed from the X-inactivation centre (Xic)o ft h e
future Xi and progressively coats the chromosome. This
is accompanied by the appearance of repressive chroma-
tin modifications, including those catalysed by polycomb
repressive complex 2 (PRC2). Xist RNA has been
proposed to play a direct role in the recruitment of
PRC2 through protein-RNA interaction [2]. An unre-
solved question has been how the Xist-PRC2 complex
becomes exclusively localised to the future Xi. Jeon and
Lee addressed this problem by studying Xist expression
from an inducible transgene in post-XCI embryonic
fibroblasts and using in situ hybridization and RT-PCR
to distinguish between endogenous and transgenic Xist
expression [3]. Transgenic Xist RNA localised to the
transgene, but, surprisingly, endogenous Xist RNA, nor-
mally localised only to Xi, was also seen to migrate to
the transgene locus. Seeking to identify a DNA element
necessary for this accumulation of Xist RNA, the
authors identified a cluster of three Yin Yang 1 (YY1)
binding sites within the Xist transgene, and, consistent
with this, found that knockdown of YY1 expression also
abrogated Xist localisation. Reasoning that YY1 might
act as a bridge between the Xic and Xist RNA, Jeon and
Lee found that Xist and YY1 interact in cells and that
YY1 interacts with the Xist repeat C region in vitro.
Consistent with this finding, an earlier study conducted
at the Lee laboratory showed that targeting the C region
with locked nucleic acid (LNA) oligonucleotides caused
displacement of Xist from the Xi [4]. On the basis of
these data, the authors proposed that YY1 acts to
anchor the Xist-PRC2 complex to the Xic by simulta-
neously binding to Xist DNA and RNA [3] (Figure 1A).
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to test the model of Jeon and Lee [3]. Is the Xist C
repeat region needed for accumulation of Xist at the
Xic? Does Xist bind YY1 and PRC2 simultaneously, and
are the YY1 DNA-binding sites and the RNA repeat C
region needed for PRC2 recruitment to the Xic?C a n
YY1 bind to DNA and RNA simultaneously, and which
parts of the protein are required? How does Xist pro-
ceed to coat the Xi after initial association with the Xic?
The authors showed that YY1 specifically binds to Xist
exon1 on the Xi and not on the Xa, which raises the
question of what causes this specificity in YY1 binding
[3]. It is possible that YY1 does not bind to the nuclea-
tion centre on Xa because of the presence of a hetero-
chromatic structure induced by the Xist antisense
ncRNA Tsix [5]. YY1 binding sites are also common in
the genome, so what prevents Xist accumulation at
these positions? Perhaps other factors are involved, such
as the RNA-binding nuclear scaffold protein hnRNPU/
SP120/SAF-A, which is also required for Xist accumula-
tion on the Xi [6]. Alternatively, in the absence of artifi-
cial transgenes, Xist RNA may be captured only by YY1
bound in cis.
Do DNA-binding proteins target other noncoding RNAs to
specific sites in chromatin?
The mechanism identified by Jeon and Lee [3] may be
responsible for the targeting of other ncRNAs to specific
sites in chromatin. The long intergenic RNA Hox anti-
sense intergenic RNA (HOTAIR) is expressed from the
HOXC locus and modulates histone H3 lysine 27
(H3K27) methylation at HOXD and several other sites
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Figure 1 Potential mechanisms through which chromatin regulator-RNA complexes target specific sites in the genome.A .T a r g e t i n g
through a sequence-specific DNA binding protein. B. Targeting through looping of the ncRNA locus to the site of activity. C. Targeting through
direct RNA-DNA interaction, for example triplex formation. D. RNA as a mechanism to target regulatory proteins to sites of transcription.
Kanhere and Jenner Silence 2012, 3:2
http://www.silencejournal.com/content/3/1/2
Page 2 of 4i nt h eg e n o m ei ntrans [7,8]. HOTAIR interacts with
PRC2 and the H3K4me2 demethylase complex lysine-
specific demethylase 1 (LSD1), thereby bridging two
activities which function to promote maintenance of the
repressed state [8]. Authors of two recent papers intro-
duced methods termed ‘chromatin isolation by RNA
purification’ (ChIRP) [9] and ‘capture hybridization ana-
lysis of RNA targets’ (CHART) [10], respectively, that
use biotinylated oligonucleotides to enrich for DNA
sequences associated with a particular RNA. ChIRP was
used to isolate HOTAIR-associated chromatin and to
identify the enriched DNA sequences by next-generation
sequencing [9]. The authors found that HOTAIR com-
monly nucleates at GA-rich DNA, raising the possibility
that the specific targeting of PRC2 and LSD1 by
HOTAIR might occur through a YY1-like factor binding
to a GA-rich motif.
Noncoding RNA targeting through chromosomal looping
Another potential mechanismi n v o l v e di nt h et a r g e t i n g
of ncRNAs to distant DNA target sites is the proximity
between loci induced by chromosomal looping (Figure
1B). The long ncRNA HOXA transcript at the distal tip
(HOTTIP) is transcribed from the 5’ end of the HOXA
locus and interacts with mixed-lineage leukaemia (MLL)
H3K4 methyltransferase complexes through WD repeat-
containing protein 5 (WDR5) [11]. Chromosomal con-
formation capture shows that chromosomal looping
brings HOTTIP into contact with downstream parts of
HOXA, and it has been proposed that this allows HOT-
TIP RNA to target WDR5-MLL to downstream genes
[11]. Chromosomal looping may also be important for
localisation of enhancer RNAs (eRNAs) to protein-cod-
ing genes [12-14]. Knockdown of eRNAs often leads to
repression of neighbouring protein-coding genes, sug-
gesting that they play a role in enhancer function [13].
One could imagine that interaction between chromoso-
mal loops may also act to bring ncRNA loci into contact
with more distant sites in trans, including those on dif-
ferent chromosomes.
Noncoding RNA targeting by triplex formation with DNA
Direct interactions between RNA and DNA sequences
also provide a potential mechanism by which ncRNAs
target chromatin regulators to specific sites (Figure 1C).
Short promoter RNAs (pRNAs) transcribed from
between ribosomal RNA (rRNA) genes directly interact
with the nucleolar remodeling complex (NoRC), and
this interaction is necessary for association of NoRC
with the promoters of rRNA genes in the nucleolus
[15]. As for Xist, the regions of the RNA required for
NoRC binding and RNA targeting appear to be distinct.
A stem-loop structure within the middle of the RNA is
necessary for interaction with NoRC [16], but a short
sequence towards the 5’ end is required for recruitment
of the RNA to nucleoli [16,17]. This region corresponds
to the DNA element T0,a n din vitro gel shift and pro-
tection assays suggest that it forms a triplex structure
with the T0 DNA sequence. In addition to allowing the
RNA to associate with rRNA promoters, this triplex
structure is recognised by DNMT3B and is required for
DNA methylation [17]. Whether triplex formation
occurs between ncRNAs and genomic DNA in cells is
unclear, but if it does, it could play a general role in tar-
geting ncRNAs to specific sites.
Targeting regulatory proteins to sites of noncoding RNA
transcription
RNA can target transcriptional regulator proteins in cis
as it is being transcribed (Figure 1D). The 60-nucleotide
transactivation response (TAR) RNA is produced after
RNA polymerase II (RNA Pol II) initiation at the HIV
long-terminal repeat [18]. In the absence of the HIV
protein Tat, further elongation by RNA Pol II is ineffi-
cient because of the action of the negative regulatory
factors DRB sensitivity-inducing factor (DSIF) and nega-
tive elongation factor (NELF) [19]. Tat binds to TAR
during transcription and recruits positive transcriptional
elongation factor b, or P-TEFb, which then phosphory-
lates RNA Pol II, DSIF and NELF, resulting in mRNA
production [19-22]. A similar mechanism may also func-
tion in the targeting of repressive complexes to sites of
transcription. Short ncRNAs are transcribed from CpG
islands at the 5’ end of human genes [23,24]. The RNAs
are produced from sites distinct from the gene promo-
ter, and their expression is anticorrelated with gene
activity [24]. Production of these short RNAs in the
absence of mRNA transcription is associated with tar-
geting of PRC2 in cis, and the RNAs directly interact
with PRC2 in vitro and in cells [24].
Summary and outlook
Growing evidence suggests that ncRNAs play an impor-
tant role in chromatin and transcriptional regulation.
How these ncRNAs are localised to specific sites in
chromatin is not yet clear, but common themes may be
emerging. Jeon and Lee’s study [3] outlines a mechanism
whereby ncRNAs localise to specific loci through inter-
action with DNA-binding proteins. A role for transcrip-
tion factors in targeting chromatin regulator-RNA
complexes is consistent with their role in initiating
changes in epigenetic modifications. It is possible that
multiple targeting mechanisms function together. For
example, chromosomal looping may provide a high local
concentration of ncRNA near a distant target site, with
DNA-binding factors then functioning to tether the
ncRNA and the associated regulatory complex to more
specific locations. Employing genomic methods such as
Kanhere and Jenner Silence 2012, 3:2
http://www.silencejournal.com/content/3/1/2
Page 3 of 4ChIRP or CHART to measure changes in RNA localisa-
tion that accompany experimental perturbations will
further help to define the mechanisms involved. Recent
results indicating that some presumed ncRNAs are asso-
ciated with ribosomes [25] highlight the importance of
determining which RNAs associate with chromatin and
which do not. Future work will lead to the derivation of
a more robust set of general principles that govern
ncRNA localisation and their role in transcriptional and
chromatin regulation.
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